Using a new airway device to improve oxygen delivery during TEE procedures
The Efficacy of Distal Pharyngeal Airway in Enhancing Oxygenation During Transesophageal Echocardiography (TEE) in Patients Sedated With Propofol
This study is testing a new airway device to see if it can improve oxygen delivery for adults undergoing transesophageal echocardiography procedures compared to the standard nasal cannula.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Miami Academic / other |
| Locations | 1 site (Miami, Florida) |
| Trial ID | NCT05974488 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of the McMurray Enhanced Airway (MEA), a flexible distal pharyngeal airway, in enhancing oxygen delivery compared to the standard nasal cannula during transesophageal echocardiography (TEE) procedures. Patients aged 18 and older who are scheduled for elective TEE will be enrolled, and their oxygenation levels will be monitored to assess the performance of the MEA. The study aims to provide insights into whether this new airway device can offer better outcomes for patients experiencing airway obstruction.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older scheduled for elective TEE procedures.
Not a fit: Patients with uncontrolled gastroesophageal reflux disease or anatomical airway obstructions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve oxygenation for patients undergoing TEE, enhancing their safety and comfort.
How similar studies have performed: While similar airway management techniques have been explored, the specific use of the McMurray Enhanced Airway in this context is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \> or = 18 years old * Patients willing to participate and provide an informed consent * Patients scheduled to undergo an elective TEE procedure. Exclusion Criteria: * Patients with history of uncontrolled gastroesophageal reflux disease * Patients with anatomical airway obstruction * Have any condition that, in the opinion of the investigator, would compromise the well-being of the patient or the study or prevent the patient from meeting or performing study requirements
Where this trial is running
Miami, Florida
- Jackson Memorial Hospital — Miami, Florida, United States (Recruiting)
Study contacts
- Principal investigator: Fouad G Souki, MD — University of Miami
- Study coordinator: Fouad G Souki, MD
- Email: fsouki@med.miami.edu
- Phone: (305) 5857435
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.